PM
Prosight Management Portfolio holdings
AUM
$410M
This Quarter Return
-22.55%
1 Year Return
-14.96%
3 Year Return
+21.81%
5 Year Return
+1.17%
10 Year Return
–
AUM
$194M
AUM Growth
+$194M
(+9.8%)
Cap. Flow
+$46.6M
Cap. Flow
% of AUM
24.06%
Top 10 Holdings %
Top 10 Hldgs %
60.4%
Holding
41
New
9
Increased
18
Reduced
8
Closed
5
Top Buys
| 1 |
WCG
Wellcare Health Plans, Inc.
WCG
|
$11.8M |
| 2 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
$9.7M |
| 3 |
Cigna
CI
|
$8.37M |
| 4 |
Galapagos
GLPG
|
$5.77M |
| 5 |
ASGN Inc
ASGN
|
$4.78M |
Top Sells
| 1 |
Tempest Therapeutics
TPST
|
$10.1M |
| 2 |
Indaptus Therapeutics
INDP
|
$4.98M |
| 3 |
SHPG
Shire pic
SHPG
|
$4.24M |
| 4 |
EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
|
$4.1M |
| 5 |
PVLA
Palvella Therapeutics, Inc. Common Stock
PVLA
|
$3.53M |
Sector Composition
| 1 | Healthcare | 90.85% |
| 2 | Technology | 2.47% |
| 3 | Financials | 0.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HNGR
1
DELISTED
Hanger Inc.
HNGR
| $22.5M | 11.64% | 1,189,399 -10,203 | -0.9% | -$193K |
|
|
RETA
2
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $14.2M | 7.33% | 253,000 +172,845 | +216% | +$9.7M |
|
|
3
Cigna
CI
$80.3B
| $13.9M | 7.19% | 73,300 +44,064 | +151% | +$8.37M |
|
|
WCG
4
DELISTED
Wellcare Health Plans, Inc.
WCG
| $11.8M | 6.09% | +50,000 | New | +$11.8M |
|
|
ARNA
5
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $10.8M | 5.58% | 277,650 +33,600 | +14% | +$1.31M |
|
6
Zimmer Biomet
ZBH
$21B
| $10.7M | 5.54% | 103,380 +39,450 | +62% | +$4.09M |
|
7
Iovance Biotherapeutics
IOVA
$807M
| $9.4M | 4.85% | 1,062,500 +347,183 | +49% | +$3.07M |
|
8
BioMarin Pharmaceuticals
BMRN
$11.2B
| $8.77M | 4.53% | 103,000 +6,572 | +7% | +$560K |
|
|
AGN
9
DELISTED
Allergan plc
AGN
| $8.21M | 4.24% | 61,400 +30,000 | +96% | +$4.01M |
|
|
ALBO
10
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $6.63M | 3.42% | 270,146 +107,241 | +66% | +$2.63M |
|
11
Assembly Biosciences
ASMB
$190M
| $6.24M | 3.22% | 275,941 +156,363 | +131% | +$3.54M |
|
|
12
Galapagos
GLPG
$2.07B
| $5.77M | 2.98% | +62,850 | New | +$5.77M |
|
|
13
Indaptus Therapeutics
INDP
$7.19M
| $5.1M | 2.63% | 676,104 -661,087 | -49% | -$4.98M |
|
|
TLGT
14
DELISTED
Teligent, Inc
TLGT
| $4.86M | 2.51% | 3,547,607 +306,846 | +9% | +$420K |
|
|
15
ASGN Inc
ASGN
$2.38B
| $4.78M | 2.47% | +87,700 | New | +$4.78M |
|
16
Viking Therapeutics
VKTX
$3.04B
| $4.77M | 2.46% | 624,000 +349,590 | +127% | +$2.67M |
|
|
MODV
17
DELISTED
ModivCare
MODV
| $4.7M | 2.43% | 78,298 -6,919 | -8% | -$415K |
|
18
Kura Oncology
KURA
$686M
| $4.45M | 2.29% | 316,581 +62,950 | +25% | +$884K |
|
19
Axogen
AXGN
$743M
| $4.27M | 2.21% | 209,088 +132,347 | +172% | +$2.7M |
|
|
SBBP
20
DELISTED
Strongbridge Biopharma plc.
SBBP
| $4.2M | 2.17% | 937,900 +514,054 | +121% | +$2.3M |
|
21
Gyre Therapeutics
GYRE
$703M
| $3.68M | 1.9% | 466,900 +230,342 | +97% | +$1.82M |
|
|
SRRA
22
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $3.37M | 1.74% | 2,553,943 -166,146 | -6% | -$219K |
|
23
Aldeyra Therapeutics
ALDX
$351M
| $3.36M | 1.73% | +404,463 | New | +$3.36M |
|
24
Centene
CNC
$14.3B
| $2.88M | 1.49% | 25,000 +5,125 | +26% | +$591K |
|
25
MacroGenics
MGNX
$112M
| $2.47M | 1.27% | 194,129 -263,346 | -58% | -$3.34M |
|